Marksans Pharma restricts trading for insiders ahead of September 2026 financial results Back
<p>Marksans Pharma Ltd. will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.</p>